Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder.
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2015
At a glance
- Drugs Vofopitant (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 29 Dec 2010 Results have been published in European Neuropsychopharmacology.
- 01 Sep 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History